Results 281 to 290 of about 776,387 (309)
Some of the next articles are maybe not open access.

Topotecan in small cell lung cancer

Lung Cancer, 1997
Lung cancer continues to be the leading cause of cancer-related death in both men and women. According to the American Cancer Society, 160,400 people are predicted to die from this disease in 1997. Approximately 20% to 25% of lung cancer cases are classified as small cell lung cancer (SCLC). Although initial response rates to chemotherapy and radiation
openaire   +2 more sources

Management of small cell cancer of the lung

Current Opinion in Pulmonary Medicine, 2000
Small cell lung cancer (SCLC) accounts for 20% to 25% of bronchogenic carcinoma cases. Combination chemotherapy offers the best chance for improved survival. Cisplatin plus etoposide appears to be the most reasonable choice for first line therapy. Increasing dose intensity, although sometimes associated with higher response rates, does not appear to ...
openaire   +2 more sources

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

Ca-A Cancer Journal for Clinicians, 2023
Ferenc Rényi-Vámos, Balázs Dome
exaly  

SMALL-CELL LUNG CANCER

The Lancet, 1980
G M, Mead   +4 more
openaire   +2 more sources

Racial and socioeconomic disparities in lung cancer screening in the United States: A systematic review

Ca-A Cancer Journal for Clinicians, 2021
Ernesto Sosa, Dan J Raz, Jae Y Kim
exaly  

SMALL-CELL LUNG CANCER

2018
Camille A. Berriochoa   +1 more
openaire   +1 more source

Small Cell Lung Cancer

1999
F. Cappuzzo   +2 more
openaire   +1 more source

Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
William D Travis, Valerie W Rusch
exaly  

American Cancer Society lung cancer screening guidelines

Ca-A Cancer Journal for Clinicians, 2013
Richard Wender   +2 more
exaly  

Home - About - Disclaimer - Privacy